Tracking Larry Robbins’ Glenview Capital Management Portfolio – Q2 2023 Update

• Glenview Capital Management’s 13F portfolio value decreased from $4.56B to $4.44B this quarter. The number of positions decreased from 54 to 49. 
• They increased CIGNA (CI), United Health Services (UHS), and Clarivate plc (CLVT) while reducing McKesson (MCK), Fiserv (FI), and Uber Technologies (UBER). 
• The top three stakes are Cigna (CI), SPDR S&P 500 Index ETF (SPY) Puts, and Tenet Healthcare (THC). They add up to ~38% of the portfolio. 

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 8/14/2023. Please visit our Tracking Larry Robbins’ Glenview Capital Management Portfolio article for an idea on his investment philosophy and our previous update for the fund’s moves during Q1 2023.

 

This quarter, Robbins’ 13F portfolio value decreased from $4.56B to $4.44B. The number of holdings decreased from 54 to 49. There are 31 positions that are significantly large. The spreadsheet below lists those larger positions individually. The top five stakes are Cigna (CI), SPDR S&P 500 Index ETF (SPY) Puts, Tenet Healthcare (THC), DXC Technology (DXC), and United Health Services (UHS). Together they are at ~49% of the 13F assets.

 

 

The spreadsheet below highlights changes to Robbins’ 13F stock holdings in Q2 2023:

 

 

 

Source: John Vincent. Data constructed from Glenview Capital Management’s 13F filings for Q1 2023 and Q2 2023.